BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18565387)

  • 1. Effect of activated charcoal on citalopram-induced QT prolongation.
    Greene SC; Brooks DE; Lovecchio F
    Ann Emerg Med; 2008 Jul; 52(1):86-7; author reply 87-8. PubMed ID: 18565387
    [No Abstract]   [Full Text] [Related]  

  • 2. Activated charcoal decreases the risk of QT prolongation after citalopram overdose.
    Isbister GK; Friberg LE; Stokes B; Buckley NA; Lee C; Gunja N; Brown SG; MacDonald E; Graudins A; Holdgate A; Duffull SB
    Ann Emerg Med; 2007 Nov; 50(5):593-600, 600.e1-46. PubMed ID: 17719135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics and pharmacodynamics of escitalopram in overdose and the effect of activated charcoal.
    van Gorp F; Duffull S; Hackett LP; Isbister GK
    Br J Clin Pharmacol; 2012 Mar; 73(3):402-10. PubMed ID: 21883384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug monitoring of a case of citalopram overdosage.
    Liotier J; Coudoré F
    Drug Chem Toxicol; 2011 Oct; 34(4):420-3. PubMed ID: 21846175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of QT prolongation with serotonin reuptake inhibitors.
    Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL
    Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of pharmacokinetic-pharmacodynamic modelling in management of QT abnormalities after citalopram overdose.
    Isbister GK; Friberg LE; Duffull SB
    Intensive Care Med; 2006 Jul; 32(7):1060-5. PubMed ID: 16791669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citalopram, QTc Prolongation, and Torsades de Pointes.
    Tampi RR; Balderas M; Carter KV; Tampi DJ; Moca M; Knudsen A; May J
    Psychosomatics; 2015; 56(1):36-43. PubMed ID: 25619672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citalopram (Celexa) and QT interval prolongation.
    Med Lett Drugs Ther; 2012 Sep; 54(1398):71-2. PubMed ID: 22992488
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study.
    Maljuric NM; Noordam R; Aarts N; Niemeijer MN; van den Berg ME; Hofman A; Kors JA; Stricker BH; Visser LE
    Br J Clin Pharmacol; 2015 Oct; 80(4):698-705. PubMed ID: 25966843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses.
    Friberg LE; Isbister GK; Duffull SB
    Br J Clin Pharmacol; 2006 Feb; 61(2):177-90. PubMed ID: 16433872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Citalopram and QT prolongation].
    Alušík Š; Paluch Z
    Vnitr Lek; 2018; 63(12):952-956. PubMed ID: 29334745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citalopram, escitalopram, and the QT interval.
    Med Lett Drugs Ther; 2013 Jul; 55(1421):59. PubMed ID: 23863918
    [No Abstract]   [Full Text] [Related]  

  • 13. Should We be Worried About QTc Prolongation Using Citalopram? A Review.
    Hutton LMJ; Cave AJ; St-Jean R; Banh HL
    J Pharm Pract; 2017 Jun; 30(3):353-358. PubMed ID: 26763342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A critical evaluation of the cardiac toxicity of citalopram: part 1.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 Nov; 49(11):13-6. PubMed ID: 22007855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescribe escitalopram instead of citalopram.
    Keller DL
    Am J Med; 2013 Jun; 126(6):e21. PubMed ID: 23684405
    [No Abstract]   [Full Text] [Related]  

  • 16. Considerations on safety concerns about citalopram prescribing.
    Sheeler RD; Ackerman MJ; Richelson E; Nelson TK; Staab JP; Tangalos EG; Dieser LM; Cunningham JL
    Mayo Clin Proc; 2012 Nov; 87(11):1042-5. PubMed ID: 23018033
    [No Abstract]   [Full Text] [Related]  

  • 17. A question about the potential cardiac toxicity of escitalopram.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Apr; 50(4):17-20. PubMed ID: 22421011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Torsade de pointes during combined treatment with risperidone and citalopram.
    Blaschke D; Parwani AS; Huemer M; Rolf S; Boldt LH; Dietz R; Haverkamp W
    Pharmacopsychiatry; 2007 Nov; 40(6):294-5. PubMed ID: 18030657
    [No Abstract]   [Full Text] [Related]  

  • 19. Citalopram, escitalopram: no more effective than other SSRIs, but more toxic.
    Prescrire Int; 2016 Apr; 25(170):98. PubMed ID: 27186623
    [No Abstract]   [Full Text] [Related]  

  • 20. Citalopram and cardiac toxicity.
    Cooke MJ; Waring WS
    Eur J Clin Pharmacol; 2013 Apr; 69(4):755-60. PubMed ID: 22996077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.